Inhibitor Therapeutics (INTI) Non Operating Interest Expenses (2009 - 2022)
Inhibitor Therapeutics' Non Operating Interest Expenses was $3,356 in Q4 2022, down 56.4% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Non Operating Interest Expenses (2009 - 2022) Analysis & Trends
For FY2022, Non Operating Interest Expenses at Inhibitor Therapeutics came in at $23,234, up 56.6% from FY2021.
- In earlier years, Non Operating Interest Expenses was $14,837 in FY2021.
- The Q4 2022 figure marks the lowest quarterly Non Operating Interest Expenses since Q4 2014.
- Per Business Quant data, INTI's Non Operating Interest Expenses in the three quarters before Q4 2022 was $7,705 (Q3 2022), $6,763 (Q2 2022) and $5,410 (Q1 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Inhibitor Therapeutics | 13.90 Mn | 6.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 3,356.00 |
| Sep 30, 2022 | 7,705.00 |
| Jun 30, 2022 | 6,763.00 |
| Mar 31, 2022 | 5,410.00 |
| Dec 31, 2021 | 24,872.00 |
| Sep 30, 2021 | -4,803.00 |
| Jun 30, 2021 | -3,547.00 |
| Mar 31, 2021 | 1,685.00 |
| Dec 31, 2014 | 950.00 |
| Sep 30, 2014 | 1,979.00 |
| Jun 30, 2014 | 24,994.00 |
| Mar 31, 2014 | 9,558.00 |
| Sep 30, 2012 | 41,666.00 |
| Jun 30, 2012 | -8,333.00 |
| Mar 31, 2012 | -12,500.00 |
| Dec 31, 2011 | -197,970.00 |
| Sep 30, 2011 | -43,404.00 |
| Jun 30, 2011 | -72,888.00 |
| Mar 31, 2011 | -67,636.00 |
| Dec 31, 2010 | -62,761.00 |
API Access
Inhibitor Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();